ARTICLE | Clinical News
ProCord regulatory update
September 20, 2004 7:00 AM UTC
FDA granted Orphan Drug designation to ProCord, an autologous incubated macrophage therapy, to improve the motor and sensory neurological outcome in cases of acute spinal cord injury (SCI). ProCord is...